Both in Biotechnology
Tarsus Pharmaceuticals vs Vericel
Over the past year TARS returned +5.2% and VCEL returned +14.3%; their daily moves had a correlation of 0.19.
TARS +5.2% VCEL +14.3%Growth of $1, one year, split-adjusted
| Metric | TARS | VCEL |
|---|---|---|
| Price | $71.68 | $41.70 |
| Market cap | $3.35B | $2.14B |
| Today | +1.30% | −3.63% |
| 1 month | −6.5% | +2.7% |
| 6 months | +18.1% | +24.7% |
| Year to date | −12.5% | +15.8% |
| 1 year | +5.2% | +14.3% |
| Revenue growth (YoY) | +69.4% | +22.5% |
| Gross margin | 93.0% | 72.8% |
| Net margin | −10.7% | 2.8% |
| P/E (TTM) | — | 88.2× |
| Price / sales | 5.5× | 7.0× |
| Net cash | $376.9M | $162.5M |
| Dividend yield | — | — |
| Volatility (60d) | 48.0% | 28.5% |
| Short % of float | 15.3% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).